Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D07JQO
|
||||
Former ID |
DIB010510
|
||||
Drug Name |
SB 249417
|
||||
Drug Type |
Antibody
|
||||
Indication | Sepsis [ICD9: 995.91; ICD10:A40, A41] | Discontinued in Phase 1 | [546894] | ||
Company |
GlaxoSmithKline
|
||||
Target and Pathway | |||||
Target(s) | Coagulation factor IX | Target Info | [526314] | ||
KEGG Pathway | Complement and coagulation cascades | ||||
PANTHER Pathway | Blood coagulation | ||||
PathWhiz Pathway | Coagulation | ||||
Reactome | Extrinsic Pathway of Fibrin Clot Formation | ||||
Intrinsic Pathway of Fibrin Clot Formation | |||||
Gamma-carboxylation of protein precursors | |||||
Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus | |||||
Removal of aminoterminal propeptides from gamma-carboxylated proteins | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.